COMMUNIQUÉS West-GlobeNewswire

PSI Names New CIO to its Senior Leadership Team
05/09/2019
Industry Veteran Brings 39 Years of IT and Software Development Experience ARLINGTON, Va., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI)—a leading provider of IT solutions to the federal [...]
Roots of Hope national suicide prevention project launched in Ottawa today
05/09/2019
From Mental Health Commission of Canada OTTAWA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today the Mental Health Commission of Canada (MHCC) officially launched the national Roots of Hope suicide prevention project in Ottawa [...]
Le projet national de prévention du suicide « Enraciner l’espoir » est lancé aujourd’hui à Ottawa
05/09/2019
De Commission de la santé mentale du Canada OTTAWA, 05 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission de la santé mentale du Canada (CSMC) a officiellement lancé à Ottawa le projet national de prévention du [...]
Agritek Holdings, Inc. Announces Intent to File Quarterly Report Ending June 30th 2019, Return to Fully Reporting Status, and Registration Statement for Up to Five Million Dollars in Equity Funding
05/09/2019
LOS ANGELES, CA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
B. Braun Successfully Integrates with West-Com at Fairchild Medical Center
05/09/2019
BETHLEHEM, Pa., Sept. 05, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced the integration of their Space™ Infusion Pump Systems with West-Com Nurse Call Systems, Inc. at Fairchild Medical Center, located in [...]
OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
05/09/2019
Major clinical progress with four differentiated therapeutic programs in immuno-oncology and autoimmune diseases; Received €25 M in milestones from collaborations with Servier and Boehringer Ingelheim €16 M turnover and [...]
ProLynx annonce la publication et le début du recrutement des patients pour l'essai d'un traitement mensuel du diabète chez le chat
05/09/2019
SAN FRANCISCO, 05 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd'hui, ProLynx a annoncé la publication de données détaillées sur le traitement du diabète de type 2 chez le chat avec le PLX039, un agoniste du récepteur du GLP-1 [...]
Pixium Vision to Participate in Multiple Upcoming Industry Events
05/09/2019
Pixium Vision to Participate in Multiple Upcoming Industry Events Paris, 5 September 2019 – 5:45 PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to [...]
Pixium Vision annonce sa participation à plusieurs évènements à venir
05/09/2019
Pixium Vision annonce sa participation à plusieurs évènements à venir Paris, 5 septembre 2019 – 17:45 CEST - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique [...]
Oxurion NV Business Update – H1 2019
05/09/2019
Positive Topline Phase 1 Results with THR-149 (Plasma Kallikrein Inhibitor) for treatment of DME Mixed Topline Results from exploratory THR-317 (anti-PlGF) Phase 2a ranibizumab combination study for the treatment of DME [...]
WeedMD Announces Upsize of its Previously Announced Bought-Deal Offering of Convertible Debenture Units to $12 Million
05/09/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a [...]
Cabaletta Bio Expands Management Team with Appointment of Brian Stalter as General Counsel
05/09/2019
Mr. Stalter joins Cabaletta with more than 20 years of general corporate and deal-making experience in small biotech and large pharma organizations PHILADELPHIA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a [...]
Generex Announces Webcast
05/09/2019
CEO Joe Moscato’s Presentation at the H.C. Wainwright 21 st ANNUAL GLOBAL INVESTMENT CONFERENCE to be Webcast by Wall Street Webcasting Monday September 9, 2019 3:25 PM MIRAMAR, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- [...]
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05/09/2019
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at a special meeting of [...]
Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics
05/09/2019
First cases already diagnosed and reported by Penn expert pathologists NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today a major [...]
BridgeBio Pharma expands its research into neuromuscular disease to include Limb-Girdle Muscular Dystrophy Type 2 (LGMD2i) with new subsidiary ML Bio Solutions
05/09/2019
Provides BridgeBio with leading scientific expertise to develop oral small molecule therapy for LGMD2i CHARLOTTE, N.C. and SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today [...]
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
05/09/2019
Oasmia Pharmaceutical AB's annual report for the fiscal year 2018/2019 is now available on the company's website www.oasmia.com . Compared to the year-end report, which was published on June 28, the financial statements [...]
Media Advisory: JDRF Brings Together Pickering Community, Researcher, and Elected Officials to Discuss Affordable Access to Life-Changing Technologies for type 1 diabetes
05/09/2019
PICKERING, Ontario, Sept. 05, 2019 (GLOBE NEWSWIRE) -- On Thursday, September 12, JDRF Canada will host a community forum to address the need for access to affordable type 1 diabetes (T1D) technologies for the more than [...]
ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
05/09/2019
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be administered once every [...]

Pages